Iwaki & Co. Ltd. | Income Statement

Fiscal year is December-November. All values JPY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
52,465
54,145
55,423
55,122
57,388
60,084
Cost of Goods Sold (COGS) incl. D&A
41,966
43,275
44,940
44,249
45,698
47,637
Gross Income
10,499
10,870
10,483
10,873
11,690
12,446
SG&A Expense
9,478
9,965
9,923
9,892
10,107
10,594
EBIT
1,021
-
559
981
1,582
1,852
Unusual Expense
6
56
6
1,141
422
17
Non Operating Income/Expense
218
162
201
157
495
127
Interest Expense
72
74
75
44
28
25
Pretax Income
1,167
948
670
52
1,647
1,980
Income Tax
412
452
814
536
387
552
Consolidated Net Income
755
496
144
587
1,259
1,428
Net Income
755
496
144
593
1,242
1,415
Net Income After Extraordinaries
755
496
144
593
1,242
1,415
Net Income Available to Common
755
496
144
593
1,242
1,415
EPS (Basic)
22.34
14.69
4.26
17.74
37.93
43.75
Basic Shares Outstanding
34
34
34
33
33
32
EPS (Diluted)
22.34
14.69
4.26
17.74
37.93
43.75
Diluted Shares Outstanding
34
34
34
33
33
32
EBITDA
1,801
1,771
1,506
1,926
2,341
2,618
Non-Operating Interest Income
6
5
2
2
2
1
Minority Interest Expense
-
-
-
6
17
13
Equity in Affiliates (Pretax)
-
7
12
8
18
6

About Iwaki & Co.

View Profile
Address
4-8-2 Nihonbashi Hon-cho
Tokyo Tokyo 103
Japan
Employees -
Website http://www.iwaki-kk.co.jp
Updated 07/08/2019
Iwaki & Co., Ltd. engages in the manufacture, trade, and wholesale of pharmaceuticals, cosmetics, chemicals, and food products. It operates through the following segments: Medical and Fine Chemical; Health and Beauty Care; Industrial Chemicals; Food; and Others. The Medical and Fine Chemical segment manufactures and sells active pharmaceutical ingredients, medical supplies, and medical equipment.